SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-02-001213
Filing Date
2002-03-15
Accepted
2002-03-15 00:00:00
Documents
4
Period of Report
2002-03-05
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 LYNX THERAPEUTICS 8-K PERIOD DATE OF MARCH 5, 2002 f79954e8-k.htm 8-K 9154
3 EXHIBIT 10.26 f79954ex10-26.txt EX-10.26 108406
4 EXHIBIT 10.27 f79954ex10-27.txt EX-10.27 34477
5 EXHIBIT 99.1 f79954ex99-1.txt EX-99.1 3636
  Complete submission text file 0000891618-02-001213.txt   157589
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 02576688
SIC: 2833 Medicinal Chemicals & Botanical Products